key: cord-0011585-xirw3t6i
authors: Mishra, Ajay Kumar; Lal, Amos; Sahu, Kamal Kant; George, Anu Anna; Sargent, Jennifer
title: Mechanisms of neurological injury in COVID -19
date: 2020-05-17
journal: World Neurosurg
DOI: 10.1016/j.wneu.2020.05.089
sha: 88486131b230a67b5b3c5b9f8369f1be1273af15
doc_id: 11585
cord_uid: xirw3t6i

nan

in detail. 1 We believe this topic is important and is continuously evolving. We have the following comments as an addition to the article.

Symptomatic patients with COVID -19 can present with mild, moderate, or severe illness.

Across all studies, patients with severe illness have multi-organ involvement. Patients with severe disease are prone to develop acute respiratory distress syndrome (ARDS), acute cardiac injury, acute renal failure, acute liver dysfunction. 2 While several patterns of central nervous system involvement have been reported among these patients, diffuse CNS involvement has been reported to be higher. 3 Multiple mechanisms could contribute to the initiation and progression of CNS injury in COVID -19 patients.

i] Cytokine storm, defined as dysfunctional, uncontrolled, continuous activation of inflammation has been consistently reported across all studies. This exaggerated inflammation has been postulated to contribute to ARDS, myocardial injury, renal failure, severity of illness, requirement of intensive care unit admission, requirement of mechanical ventilation, and mortality. This has been diagnosed with an elevated level of inflammatory markers including Creactive protein, leukocytes, pro calcitonin, proBNP, ferritin, interleukins, and various other inflammatory markers. While diffuse CNS involvement is noted to be higher among patients with severe illness, a temporal association between inflammatory markers and CNS dysfunction

is not yet shown. 4, 5 ii] Autopsy studies on COVID -19 patients have been limited. Direct viral invasion has been reported in various organs including lung, liver, and heart. However, no reports have yet identified the virus, or viral particles in the brain. 6 Iii] hypoxia induced apoptosis and ischemia, presenting in most patients as multiorgan dysfunction. 7 iv] prothrombotic state secondary to endothelial injury, thrombocytopenia, deranged coagulation parameters as evident from the raised D-dimer, fibrinogen, prothrombin time. [9] [10] [11] Finally, cerebrovascular injury is being commonly reported in patients with COVID-19. Studies have shown that patients with severe COVID-19 had higher cardio-cerebrovascular comorbidities including older age, hypertension, diabetes mellitus, hyperlipidemia, heart failure, coronary artery disease, and cerebrovascular disease. 12, 13 A recent study also showed that patients with severe COVID -19 had higher cerebrovascular events as compared to patients without severe Illness. 3 We agree with the authors that future studies will be instrumental in clarifying patterns, predictors and outcome of COVID -19 related neurological injury,

Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community

COVID-2019: update on epidemiology, disease spread and management

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Patterns of heart Injury in COVID -19 and relation to outcome

Neurologic Features in Severe SARS-CoV-2 Infection

A review of cardiac manifestations and predictors of outcome in patients with COVID -19. Heart Lung

Latest updates on COVID-2019: A changing paradigm shift

Nervous system involvement after infection with COVID-19 and other coronaviruses

An update on CT chest findings in coronavirus disease-19 (COVID-19)

Reporting of all cardiac medications and their outcome in COVID -19

Understanding pathways to death in patients with COVID-19